Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients.
Baselga J, Llombart-Cussac A, Bellet M, Guillem-Porta V, Enas N, Krejcy K, Carrasco E, Kayitalire L, Kuta M, Lluch A, Vodvarka P, Kerbrat P, Namer M, Petruzelka L. Baselga J, et al. Among authors: kuta m. Ann Oncol. 2003 Sep;14(9):1383-90. doi: 10.1093/annonc/mdg368. Ann Oncol. 2003. PMID: 12954577 Free article. Clinical Trial.
[Tamoxifen or tamoxifen in combination with chemotherapy in adjuvant therapy of breast carcinoma. Results of a multicenter randomized study].
Pribylová O, Petruzelka L, Honová H, Fischer J, Bustová I, Siffnerová H, Kůta M, Miller V, Hacklová M, Machácek J, Kohoutek M, Vodvárka P, Kyselá T, Tajblová J, Suk J, Dorazilová V, Vedralová J, Bauer J. Pribylová O, et al. Among authors: kuta m. Sb Lek. 2001;102(1):65-76. Sb Lek. 2001. PMID: 11830920 Clinical Trial. Czech.
[Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
Pribylová O, Petruzelka L, Honová H, Fischer J, Bustová I, Siffnerová H, Kůta M, Miller V, Hacklová M, Machácek J, Kohoutek M, Vodvárka P, Kyselá T, Tajblová J, Suk J, Dorazilová V, Bauer J. Pribylová O, et al. Among authors: kuta m. Sb Lek. 1998;99(1):25-31. Sb Lek. 1998. PMID: 9748796 Clinical Trial. Czech.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtů H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T, Kůta M. Zatloukal P, et al. Among authors: kuta m. Lung Cancer. 2003 Sep;41(3):321-31. doi: 10.1016/s0169-5002(03)00233-2. Lung Cancer. 2003. PMID: 12928123 Clinical Trial.
[IKARUS Project--incidence of bone events in breast cancer: retrospective analysis of patients in oncological centres in the Czech Republic and Slovakia].
Fínek J, Prausová J, Cmejlová V, Cwiertka K, Svébisová H, Vyzula R, Holánek M, Bodorová M, Slavícek L, Kubecová M, Loukotková L, Neumanová R, Lepeyová K, Lysý M, Smejkal J, Soumarová R, Rysková J, Kalisová K, Machanová J, Bohusová M, Alaksa V, Stresko M, Samanová T, Kůta M, Vanásek J, Vondrácková K, Vargovcíková M, Petera J, Pritzová E, Bednarík O, Hlavácová A, Jancoková I, Szeghöová O, Dammak A, Lesková J, Chroust K, Dusek L. Fínek J, et al. Among authors: kuta m. Klin Onkol. 2009;22(4):154-62. Klin Onkol. 2009. PMID: 19731877 Czech.
Small-molecule non-peptide antagonists of the PACAP receptor attenuate acute restraint stress-induced anxiety-like behaviors in mice.
Shintani Y, Yamano Y, Kuta M, Takeshita R, Takuma K, Okada T, Toyooka N, Takasaki I, Miyata A, Kurihara T, Hashimoto H, Hayata-Takano A. Shintani Y, et al. Among authors: kuta m. Biochem Biophys Res Commun. 2022 Nov 26;631:146-151. doi: 10.1016/j.bbrc.2022.09.079. Epub 2022 Sep 26. Biochem Biophys Res Commun. 2022. PMID: 36194909 Free article.
Regioselective glycosylation of novobiocin alters activity.
Sun G, de Resende PE, Stapleton P, Kuta M, Wang X, Haider S, Yang M. Sun G, et al. Among authors: kuta m. Carbohydr Res. 2017 Nov 27;452:116-121. doi: 10.1016/j.carres.2017.10.011. Epub 2017 Oct 22. Carbohydr Res. 2017. PMID: 29096184
Selectivity of major isoquinoline alkaloids from Chelidonium majus towards telomeric G-quadruplex: A study using a transition-FRET (t-FRET) assay.
Noureini SK, Esmaeili H, Abachi F, Khiali S, Islam B, Kuta M, Saboury AA, Hoffmann M, Sponer J, Parkinson G, Haider S. Noureini SK, et al. Among authors: kuta m. Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):2020-2030. doi: 10.1016/j.bbagen.2017.05.002. Epub 2017 May 4. Biochim Biophys Acta Gen Subj. 2017. PMID: 28479277
20 results